fashion -WSS

fashion

author：entertainment 2025-10-01 21:37:09 - browse：4438

Roche HQ — SEBASTIEN BOZON/AFP via Getty Images

The multibillion-dollar hunt for what many drugmakers hope will be the next big immunotherapy target has had no shortage of twists and tea-leaf-reading. In the wee hours of Wednesday morning, it got another.

Roche confirmed it accidentally released interim data from a closely watched clinical trial testing whether blocking that target — a protein on T cells known as TIGIT — can enable non-small lung cancer patients to live longer than standard immunotherapy alone.

The announcement release came hours after Evercore analyst Umer Raffat emailed investors that he had found a presentation on a Roche media portal, presumably uploaded by accident.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： Leukemia patients are helped by Syndax's new type of therapy

focus

WSS

The woman behind the Dana Farber

Sarepta Duchenne therapy fails to meet primary endpoint in trial

FDA approves world's first CRISPR

Brain injuries and the importance of a second opinion

AbbVie buys Immunogen, maker of targeted cancer drugs, for $10B

STAT letters to the editor on burnt

entertainment

fashion

knowledge

At least 13 dead in Texas as scorching temps continue

Inari Medical to buy amputation prevention company LimFlow

Medical records are filled with copy

Congenital heart disease patients face new threat of heart failure

DIEP, the 'gold standard' of breast reconstruction, is under threat

What is microchimerism and how does it affect maternal health?

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Congenital heart disease patients face new threat of heart failure

Medical records are filled with copy

What PEPFAR has meant on the ground in Ukraine

hotspot

Teach medical students about patients with intellectual disabilities

CMS should re

Humans aren't the only ones with an imagination. Rats have it too

CMS should re

Humans aren't the only ones with an imagination. Rats have it too

Radiology is caught between AI's potential and concern for patients

focus

focus

entertainment

explore